Skip to main content

Security report for 4nrx-uk.md

4NRX Ltd · Healthcare · United Kingdom

Medium risk. 5 critical or high findings in Security headers, GDPR outside view and 1 other check.

Security score

67/100

Risk levelMedium

0–100, higher is better. How it is calculated

4NRX Ltd operates an established online pharmacy website, 4nrx-uk.md, providing competitively priced pharmaceutical products including brand name and generic drugs. The business targets UK and international customers seeking convenient online purchase and home delivery of medicines. The website features a broad product catalog, company news, and customer support via contact forms and live chat, reflecting a mature e-commerce healthcare business. Technically, the site uses standard web technologies including JavaScript, Google Analytics, Google Tag Manager, and a live chat widget, with a custom or unknown CMS. The site is moderately optimized for performance and mobile use, with good SEO practices but basic accessibility features. Security posture is adequate with HTTPS enforced and no exposed sensitive data, but lacks important security headers and cookie consent mechanisms, which are recommended for compliance and enhanced protection. WHOIS data confirms the domain is long-established since 1999, with registrant information consistent with the business claims, supporting legitimacy. Overall, the website is professional and trustworthy but would benefit from improved privacy compliance and security hardening.

Scanned

NIS2 and GDPR posture

GDPR outside view
53/ 100 · Medium
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

5 findings rated critical or high. Fix these first.

  1. Security headers

    Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.

    • High

      Missing Strict-Transport-Security header

      Forces HTTPS connections

      What to do: Add "Strict-Transport-Security: max-age=31536000; includeSubDomains; preload"

      • CWE-319
      • OWASP A04:2025
      • ASVS V3.4.1
    • High

      Missing Content-Security-Policy header

      Controls resources the browser is allowed to load

      What to do: Implement a Content-Security-Policy appropriate for your application

      • ASVS V3.4.3
      • OWASP Secure Headers: OWASP Secure Headers Project recommends Content-Security-Policy: default-src 'self'; form-action 'self'; base-uri 'self'; object-src 'none';…

  2. GDPR outside view

    These are the privacy signals visitors and data protection authorities look for under GDPR.

    • High

      No Cookie Policy found

      GDPR requires clear information about cookie usage

      What to do: Add a dedicated cookie policy explaining cookie usage and purposes

    • High

      No Cookie Consent Banner found

      GDPR requires explicit consent for non-essential cookies

      What to do: Implement a cookie consent banner that appears on first visit

  3. SSL/TLS

    TLS encrypts the connection and proves the site is really yours. Weak or expiring certificates trigger browser warnings and put traffic at risk.

    • High

      Weak Protocols Supported

      Server supports weak protocols: TLSv1.1

      What to do: Disable TLS 1.0, TLS 1.1, and all SSL versions

      • CWE-327
      • OWASP A04:2025
      • ASVS V12.1.1

Need hands-on remediation? Email guard@offseq.com

Keep watching 4nrx-uk.md

This scan found 24 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. The full timeline opens with your unlock code.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
62
Security headers
55
Email security
70
DNS health
60
Network security
100
GDPR outside view
53
Average
67

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

4NRX Ltd holds a solid market position as a medium-sized online pharmacy with a history dating back to 1999. Its competitive advantage lies in a wide product range and direct-to-door delivery model. The business model focuses on retail e-commerce of pharmaceutical products, targeting consumers in the UK and beyond. Revenue streams likely derive from direct sales of medicines and health products. The company maintains an active online presence including social media channels on Facebook, Instagram, and Twitter, enhancing customer engagement. Shipping notices and company news indicate operational transparency and responsiveness to external factors such as UK strikes and COVID-19 impacts. No evidence of partnerships or subsidiaries was found in the data. The company appears to maintain a moderate digital marketing and analytics ecosystem.

Security posture

The website enforces HTTPS, ensuring encrypted communications, and uses secure forms for data input. However, it lacks critical security headers such as Content-Security-Policy and Strict-Transport-Security, which could mitigate risks like cross-site scripting and protocol downgrade attacks. No explicit security or incident response policies are published, and no dedicated security contact channels are provided. The absence of a cookie consent mechanism may expose the company to privacy compliance risks under GDPR. The use of third-party scripts like Google Analytics and JivoSite live chat introduces potential privacy considerations. Overall, the security maturity is moderate but requires enhancements to align with best practices and regulatory requirements.

Recommendations

  1. Implement comprehensive security headers including Content-Security-Policy, X-Frame-Options, and Strict-Transport-Security.
  2. Add a cookie consent banner and detailed cookie policy to improve GDPR compliance.
  3. Publish a formal security policy and provide incident response contact information to enhance transparency and trust.
  4. Conduct regular security audits of third-party scripts and dependencies to minimize vulnerabilities.
  5. Enhance accessibility and mobile optimization to improve user experience and broaden audience reach.
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
4NRX Ltd
Description
4NRX pharmacy provides competitively priced drugs and medicine delivered right to your door. Operating since 1999 with over 2,000 products including brand name and generic drugs.
Key services
Online sale of prescription and non-prescription drugs, Home delivery of medicines, Customer support via contact form and live chat
Content quality
good
Branding
consistent

Technology

Stack
JavaScript, Google Analytics, Google Tag Manager, JivoSite live chat
Performance
moderate
Mobile
basic
Accessibility
basic
SEO
good

Security

Observed score
65/100
Good practices seen
  • HTTPS enforced
  • No visible exposed sensitive data
  • Use of secure forms

Analytics and tracking

Services
Google Analytics, Google Tag Manager
Tracking level
moderate
Privacy practices
basic

Advertising

Marketing tools
JivoSite live chat
Transparency
basic

Site quality

Design
good
User experience
good
Content relevance
good
Navigation
good
Professionalism
good
Trustworthiness
moderate

Key observations

  1. Website is a well-established online pharmacy targeting UK customers.
  2. Content is comprehensive with detailed product listings and company news.
  3. No explicit privacy or cookie consent mechanisms detected, which may impact compliance.
  4. Security headers are missing, representing an area for improvement.
  5. Use of common analytics and live chat tools indicates moderate digital maturity.
  6. No suspicious or malicious content detected.
  7. Social media presence on Facebook, Instagram, and Twitter is linked.
  8. WHOIS data supports the legitimacy and consistency of the business.
Technical notes

Notes

The website uses a custom or unknown CMS with JavaScript-based enhancements including Google Analytics, Google Tag Manager, and JivoSite live chat for customer support. The HTML structure is valid with appropriate meta tags for SEO. Performance is moderate with asynchronous loading of external scripts. Mobile optimization is basic but functional. Accessibility features are minimal, suggesting room for improvement. No modern web frameworks or platforms were detected. Hosting provider details are not disclosed. The technical stack supports the business needs but could benefit from modernization and improved security configurations.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with 4nrx-uk.md. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review 4nrx-uk.md.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.